Genetic Epilepsies
For people living with rare, genetically driven forms of epilepsy where seizures remain uncontrolled and treatment options are limited.
Inspired by Patients.Guided by Biology.Accelerated by AI.
At Navion Neurosciences, we exist to solve problems for people living with conditions driven by abnormal neuronal firing, including uncontrolled seizures and chronic pain.
Through AI/ML enhanced chemistry, precision science and deep understanding of the nervous system, we are developing a new generation of medicines designed to restore control, improve daily life and bring hope to families.
Our Mission
We are pioneering precision sodium channel therapeutics to address debilitating neurological conditions—starting with genetic epilepsies and chronic neuropathic pain.
We aim to deliver meaningful, lasting impact where current treatments fall short.
What we're working on
Two areas. One goal. Better lives.
Chronic Neuropathic Pain
For people whose lives are limited by persistent nerve pain—often with no effective relief.
How we're different
Precision science with patients at the center
Targeted. Not blunt
We precisely modulate the sodium channels that drive disease—aiming for efficacy without unnecessary side effects.
Built on human biology
We integrate genetics, patient-derived data, and advanced models to focus on what matters most.
AI-enabled discovery
Our proprietary, NaViGATion™ engine combines AI, structural biology, and in vivo data to advance the right molecules.
Driven by compassion
Every decision we make is guided by the people we hope to help.
Our team
Experienced leaders building the future of precision neuroscience.
Deep ion-channel, neurology, and drug discovery expertise. United by purpose.
Click a team member to read their bio.
News
Latest from Navion
News is coming soon.
Please check back for company updates and announcements.